SYMBOTIC INC (SYM)

US87151X1019 - Common Stock

30.56  +1.07 (+3.63%)

After market: 38.65 +8.09 (+26.47%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SYM. SYM was compared to 131 industry peers in the Machinery industry. While SYM seems to be doing ok healthwise, there are quite some concerns on its profitability. SYM is valued quite expensively, but it does show have an excellent growth rating.



1

1. Profitability

1.1 Basic Checks

In the past year SYM has reported negative net income.
SYM had a positive operating cash flow in the past year.
SYM had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: SYM reported negative operating cash flow in multiple years.

1.2 Ratios

SYM has a worse Return On Assets (-1.10%) than 70.08% of its industry peers.
Looking at the Return On Equity, with a value of -4.11%, SYM is doing worse than 70.08% of the companies in the same industry.
Industry RankSector Rank
ROA -1.1%
ROE -4.11%
ROIC N/A
ROA(3y)-19.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SYM has a worse Gross Margin (14.34%) than 84.25% of its industry peers.
SYM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

SYM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SYM has more shares outstanding
SYM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

SYM has an Altman-Z score of 8.91. This indicates that SYM is financially healthy and has little risk of bankruptcy at the moment.
SYM has a Altman-Z score of 8.91. This is amongst the best in the industry. SYM outperforms 92.91% of its industry peers.
There is no outstanding debt for SYM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.91
ROIC/WACCN/A
WACC9.15%

2.3 Liquidity

A Current Ratio of 1.31 indicates that SYM should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.31, SYM is doing worse than 83.46% of the companies in the same industry.
SYM has a Quick Ratio of 1.18. This is a normal value and indicates that SYM is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.18, SYM perfoms like the industry average, outperforming 44.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.18

7

3. Growth

3.1 Past

SYM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.06%, which is quite impressive.
Looking at the last year, SYM shows a very strong growth in Revenue. The Revenue has grown by 62.86%.
Measured over the past years, SYM shows a very strong growth in Revenue. The Revenue has been growing by 133.79% on average per year.
EPS 1Y (TTM)53.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.86%
Revenue 1Y (TTM)62.86%
Revenue growth 3Y133.79%
Revenue growth 5YN/A
Sales Q2Q%57.73%

3.2 Future

SYM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.24% yearly.
Based on estimates for the next years, SYM will show a very strong growth in Revenue. The Revenue will grow by 43.98% on average per year.
EPS Next Y123.76%
EPS Next 2Y75.2%
EPS Next 3Y62.24%
EPS Next 5YN/A
Revenue Next Year60.74%
Revenue Next 2Y47.11%
Revenue Next 3Y43.98%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SYM. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 84.05 indicates a quite expensive valuation of SYM.
SYM's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SYM is more expensive than 68.50% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SYM to the average of the S&P500 Index (23.50), we can say SYM is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 84.05

4.2 Price Multiples

SYM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. SYM is more expensive than 66.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF 259.33
EV/EBITDA N/A

4.3 Compensation for Growth

SYM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SYM's earnings are expected to grow with 62.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.2%
EPS Next 3Y62.24%

0

5. Dividend

5.1 Amount

No dividends for SYM!.
Industry RankSector Rank
Dividend Yield N/A

SYMBOTIC INC

NASDAQ:SYM (11/18/2024, 8:00:01 PM)

After market: 38.65 +8.09 (+26.47%)

30.56

+1.07 (+3.63%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap17.90B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 84.05
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.1%
ROE -4.11%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 14.34%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.31
Quick Ratio 1.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)53.06%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y123.76%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)62.86%
Revenue growth 3Y133.79%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y